Kelly Deck

Kelly Deck

No open positions remaining

Net worth: - $ as of 2026-06-29

46 year
Health Technology
Commercial Services

Profile

Kelly Devine Deck currently works at Reuben H.
Fleet Science Center, as Trustee and Inhibrx Biosciences, Inc., as Chief Financial Officer & Executive Vice President.
Ms. Deck also formerly worked at Apricus Biosciences, Inc., as Executive Director-Finance from 2013 to 2018 and Sanofi AATD, Inc., as Chief Financial Officer.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
2026-04-06 0 ( -.--% ) - $ 2026-06-29

Kelly Deck active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Kelly Deck

CompaniesPositionEnd
INHIBRX, INC. Director of Finance/CFO 2024-05-29
Director of Finance/CFO 2017-12-31
See the detail of Kelly Deck's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

20

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies3

Health Technology

Health Technology

Commercial Services